{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T08:04:45Z","timestamp":1793779485672,"version":"4.6.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA035165"],"award-info":[{"award-number":["T32DA035165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["anesthesiology.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anesthesiology Clinics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.anclin.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T08:00:45Z","timestamp":1681459245000},"page":"357-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ketamine for Complex Regional Pain Syndrome"],"prefix":"10.1016","volume":"41","author":[{"given":"Theresa R.","family":"Lii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.anclin.2023.03.005_bib1","first-page":"4","article-title":"Complex regional pain syndrome (CRPS) type I: historical perspective and critical issues","volume":"12","author":"Iolascon","year":"2015","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"8","key":"10.1016\/j.anclin.2023.03.005_bib2","first-page":"830.e1","article-title":"Distribution of signs and symptoms of Complex Regional Pain Syndrome type I in patients meeting the diagnostic criteria of the International Association for the Study of Pain","volume":"15","author":"de Boer","year":"2011","journal-title":"Eur J Pain"},{"key":"10.1016\/j.anclin.2023.03.005_bib3","article-title":"ICD-11 Development Version Text relating to CRPS","author":"The International Association of Pain (IASP)","year":"2021","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.anclin.2023.03.005_bib4","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1097\/j.pain.0000000000002245","article-title":"The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria","volume":"162","author":"Goebel","year":"2021","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0304-3959(03)00065-4","article-title":"Complex regional pain syndrome type I: incidence and prevalence in Olmsted County, a population-based study","volume":"103","author":"Sandroni","year":"2003","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pain.2006.09.008","article-title":"The incidence of complex regional pain syndrome: A population-based study","volume":"129","author":"de Mos","year":"2007","journal-title":"Pain"},{"issue":"Suppl 2","key":"10.1016\/j.anclin.2023.03.005_bib7","doi-asserted-by":"crossref","first-page":"s65","DOI":"10.1007\/s10072-005-0410-0","article-title":"Epidemiology of typical and atypical craniofacial neuralgias","volume":"26","author":"Manzoni","year":"2005","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib8","first-page":"E257","article-title":"Prevalence of Specific Types of Pain Diagnoses in a Sample of United States Adults","volume":"20","author":"Murphy","year":"2017","journal-title":"Pain Physician"},{"issue":"8","key":"10.1016\/j.anclin.2023.03.005_bib9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/01.WNL.0000028686.74056.E3","article-title":"Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy","volume":"59","author":"Kemler","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/AJP.0b013e31818ecea5","article-title":"The Natural History of Complex Regional Pain Syndrome","volume":"25","author":"Schwartzman","year":"2009","journal-title":"Clin J Pain"},{"issue":"10","key":"10.1016\/j.anclin.2023.03.005_bib11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/14737175.2016.1206817","article-title":"Dorsal root ganglion stimulation approval by the Food and Drug Administration: advice on evolving the process","volume":"16","author":"Deer","year":"2016","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"10.1016\/j.anclin.2023.03.005_bib12","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.spinee.2015.04.043","article-title":"Spinal cord stimulation: a review of the safety literature and proposal for perioperative evaluation and management","volume":"15","author":"Walsh","year":"2015","journal-title":"Spine J"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib13","first-page":"292","article-title":"Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial","volume":"108","author":"Kemler","year":"2008","journal-title":"J\u00a0Neurosurg"},{"issue":"9","key":"10.1016\/j.anclin.2023.03.005_bib14","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM200008313430904","article-title":"Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy","volume":"343","author":"Kemler","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/j.pain.0000000000000814","article-title":"Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12\u00a0months: a randomized comparative trial","volume":"158","author":"Deer","year":"2017","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/j.pain.0000000000002405","article-title":"A\u00a0prospective long-term follow-up of dorsal root ganglion stimulation for the management of chronic intractable pain","volume":"163","author":"Eldabe","year":"2022","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3959(94)90149-X","article-title":"Response of chronic neuropathic pain syndromes to ketamine: a preliminary study","volume":"56","author":"Backonja","year":"1994","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pain.2009.08.015","article-title":"Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study","volume":"147","author":"Schwartzman","year":"2009","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.005_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pain.2009.06.023","article-title":"Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1","volume":"145","author":"Sigtermans","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.anclin.2023.03.005_bib20","article-title":"Interventions for treating pain and disability in adults with complex regional pain syndrome- an overview of systematic reviews","volume":"4","author":"O\u2019Connell","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anclin.2023.03.005_bib21","article-title":"Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists","volume":"1","author":"Cohen","year":"2018","journal-title":"Reg Anesth Pain Med"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11916-018-0664-x","article-title":"The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysis","volume":"22","author":"Zhao","year":"2018","journal-title":"Curr Pain Headache Rep"},{"issue":"6","key":"10.1016\/j.anclin.2023.03.005_bib23","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/ALN.0000000000003577","article-title":"Ketamine Pharmacokinetics: A Systematic Review of the Literature, Meta-analysis, and Population Analysis","volume":"133","author":"Kamp","year":"2020","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.anclin.2023.03.005_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0166-2236(87)90175-5","article-title":"NMDA receptors - their role in long-term potentiation","volume":"10","author":"Collingridge","year":"1987","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0165-0173(02)00202-3","article-title":"Long-term potentiation in spinothalamic neurons","volume":"40","author":"Willis","year":"2002","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.anclin.2023.03.005_bib26","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1186\/1744-8069-7-20","article-title":"Long-Term Potentiation in Spinal Nociceptive Pathways as a Novel Target for Pain Therapy","volume":"7","author":"Ruscheweyh","year":"2011","journal-title":"Mol Pain"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3959(94)00139-6","article-title":"Beneficial effects of ketamine in a chronic pain state with allodynia, possibly due to central sensitization","volume":"60","author":"Persson","year":"1995","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.anclin.2023.03.005_bib28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1399-6576.1997.tb04854.x","article-title":"Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery","volume":"41","author":"Stubhaug","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tacc.2014.03.002","article-title":"Ketamine \u2013 More mechanisms of action than just NMDA blockade","volume":"4","author":"Sleigh","year":"2014","journal-title":"Trends in Anaesthesia and Critical Care"},{"issue":"5","key":"10.1016\/j.anclin.2023.03.005_bib30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbi.2006.10.009","article-title":"Changes in immune and glial markers in the CSF of patients with Complex Regional Pain Syndrome","volume":"21","author":"Alexander","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"48","key":"10.1016\/j.anclin.2023.03.005_bib31","doi-asserted-by":"crossref","first-page":"17370","DOI":"10.1523\/JNEUROSCI.4152-11.2011","article-title":"Microglial Ca2+-Activated K+ Channels Are Possible Molecular Targets for the Analgesic Effects of S-Ketamine on Neuropathic Pain","volume":"31","author":"Hayashi","year":"2011","journal-title":"J\u00a0Neurosci"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-8-6","article-title":"Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain","volume":"8","author":"Mei","year":"2011","journal-title":"J\u00a0Neuroinflammation"},{"issue":"6","key":"10.1016\/j.anclin.2023.03.005_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cns.12104","article-title":"Ketamine and Peripheral Inflammation","volume":"19","author":"De Kock","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1213\/00000539-199808000-00006","article-title":"Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass","volume":"87","author":"Roytblat","year":"1998","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.anclin.2023.03.005_bib35","first-page":"802","article-title":"[Effects of subanesthetic dose of ketamine on perioperative serum cytokines in orthotopic liver transplantation]","volume":"26","author":"Yang","year":"2006","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.anclin.2023.03.005_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12974-021-02245-5","article-title":"Plasma inflammatory cytokines and treatment-resistant depression with comorbid pain: improvement by ketamine","volume":"18","author":"Zhou","year":"2021","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.anclin.2023.03.005_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.anclin.2023.03.005_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A\u00a0systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 \u2013 January 2019","volume":"277","author":"Marcantoni","year":"2020","journal-title":"J\u00a0Affect Disord"},{"issue":"20","key":"10.1016\/j.anclin.2023.03.005_bib39","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1001\/archinte.163.20.2433","article-title":"Depression and Pain Comorbidity: A Literature Review","volume":"163","author":"Bair","year":"2003","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.anclin.2023.03.005_bib40","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/j.pain.0000000000000542","article-title":"Depression in patients with chronic pain attending a specialised pain treatment centre: prevalence and impact on health care costs","volume":"157","author":"Rayner","year":"2016","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.anclin.2023.03.005_bib41","first-page":"964","article-title":"Reciprocal Relationship Between Pain and Depression: A 12-Month Longitudinal Analysis in Primary Care","volume":"12","author":"Kroenke","year":"2011","journal-title":"J\u00a0Pain"},{"issue":"8","key":"10.1016\/j.anclin.2023.03.005_bib42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/AJP.0000000000000007","article-title":"Relationships Between Psychological Factors, Pain, and Disability in Complex Regional Pain Syndrome and Low Back Pain","volume":"30","author":"Bean","year":"2014","journal-title":"Clin J Pain"},{"key":"10.1016\/j.anclin.2023.03.005_bib43","doi-asserted-by":"crossref","first-page":"109838","DOI":"10.1016\/j.pnpbp.2019.109838","article-title":"Simultaneous EEG\/fMRI recorded during ketamine infusion in patients with major depressive disorder","volume":"99","author":"McMillan","year":"2020","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatr"},{"issue":"12","key":"10.1016\/j.anclin.2023.03.005_bib44","first-page":"2368","article-title":"CNS Measures of Pain Responses Pre- and Post-Anesthetic Ketamine in a Patient with Complex Regional Pain Syndrome","volume":"16","author":"Becerra","year":"2015","journal-title":"Pain Med"},{"key":"10.1016\/j.anclin.2023.03.005_bib45","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320916657","article-title":"Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers","volume":"10","author":"Matveychuk","year":"2020","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib46","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1213\/ANE.0000000000001787","article-title":"Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization","volume":"124","author":"Maher","year":"2017","journal-title":"Anesth Analg"},{"issue":"14","key":"10.1016\/j.anclin.2023.03.005_bib47","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1517\/14656566.2010.515978","article-title":"Ketamine for the treatment of chronic non-cancer pain","volume":"11","author":"Noppers","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1213\/ANE.0000000000004185","article-title":"Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"129","author":"Orhurhu","year":"2019","journal-title":"Anesth Analg"},{"issue":"9","key":"10.1016\/j.anclin.2023.03.005_bib49","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ejpain.2011.03.008","article-title":"Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo-controlled trial","volume":"15","author":"Noppers","year":"2011","journal-title":"Eur J Pain"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ALN.0000000000003345","article-title":"Ketamine and Magnesium for Refractory Neuropathic Pain","volume":"133","author":"Pickering","year":"2020","journal-title":"Anesthesiology"},{"issue":"8","key":"10.1016\/j.anclin.2023.03.005_bib51","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1526-4637.2007.00402.x","article-title":"Efficacy of Ketamine in Anesthetic Dosage for the Treatment of Refractory Complex Regional Pain Syndrome: An Open-Label Phase II Study","volume":"9","author":"Kiefer","year":"2008","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib52","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ejp.1914","article-title":"Ketamine in chronic pain: A Delphi survey","volume":"26","author":"Voute","year":"2022","journal-title":"Eur J Pain"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/sjpain-2021-0079","article-title":"Ketamine therapy for chronic pain in The Netherlands: a nationwide survey","volume":"22","author":"Mangnus","year":"2022","journal-title":"Scandinavian Journal of Pain"},{"issue":"1\u20132","key":"10.1016\/j.anclin.2023.03.005_bib54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0006-8993(97)01247-X","article-title":"Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects","volume":"781","author":"Jevtovic-Todorovic","year":"1998","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.anclin.2023.03.005_bib55","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/AJP.0000000000000831","article-title":"Optimizing the Treatment of CRPS With Ketamine","volume":"36","author":"Kirkpatrick","year":"2020","journal-title":"Clin J Pain"},{"issue":"5","key":"10.1016\/j.anclin.2023.03.005_bib56","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejpain.2009.09.005","article-title":"Use of oral ketamine in chronic pain management: A review","volume":"14","author":"Blonk","year":"2010","journal-title":"Eur J Pain"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.005_bib57","first-page":"27","article-title":"Ketamine as an Analgesic","volume":"16","author":"Kronenberg","year":"2002","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"5","key":"10.1016\/j.anclin.2023.03.005_bib58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jps.2600710516","article-title":"Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans","volume":"71","author":"Clements","year":"1982","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000542-198202000-00007","article-title":"Ketamine--its pharmacology and therapeutic uses","volume":"56","author":"White","year":"1982","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib61","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pbb.2008.05.011","article-title":"Effects of norketamine enantiomers in rodent models of persistent pain","volume":"90","author":"Holtman","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.anclin.2023.03.005_bib62","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/BF03017431","article-title":"Short- and long-term efficacy of oral ketamine in eight chronic-pain patients","volume":"49","author":"Furuhashi-Yonaha","year":"2002","journal-title":"Can J Anaesth"},{"issue":"7","key":"10.1016\/j.anclin.2023.03.005_bib63","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ejp.624","article-title":"Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5-year study of 51 patients","volume":"19","author":"Marchetti","year":"2015","journal-title":"Eur J Pain"},{"key":"10.1016\/j.anclin.2023.03.005_bib64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.psychres.2018.05.050","article-title":"The profile of cognitive impairments in chronic ketamine users","volume":"266","author":"Ke","year":"2018","journal-title":"Psychiatry Res"},{"issue":"6","key":"10.1016\/j.anclin.2023.03.005_bib65","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/0897190014525754","article-title":"Ketamine: An Update on Its Abuse","volume":"27","author":"Bokor","year":"2014","journal-title":"J Pharm Pract"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.336","article-title":"Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers","volume":"24","author":"Yanagihara","year":"2003","journal-title":"Biopharm Drug Dispos"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.005_bib67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/phar.2090","article-title":"Intranasal Ketamine and Its Potential Role in Cancer-Related Pain","volume":"38","author":"Singh","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.005_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173253","article-title":"Intranasal ketamine for procedural sedation and analgesia in children: A systematic review","volume":"12","author":"Poonai","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib69","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/AJP.0000000000000918","article-title":"Intranasal Ketamine for Acute Pain","volume":"37","author":"Rocchio","year":"2021","journal-title":"Clin J Pain"},{"issue":"2","key":"10.1016\/j.anclin.2023.03.005_bib70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/jamapediatrics.2018.4582","article-title":"Effect of Intranasal Ketamine vs Fentanyl on Pain Reduction for Extremity Injuries in Children: The PRIME Randomized Clinical Trial","volume":"173","author":"Frey","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib71","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00345-020-03319-4","article-title":"Intranasal ketamine versus intravenous morphine for pain management in patients with renal colic: a double-blind, randomized, controlled trial","volume":"39","author":"Pouraghaei","year":"2021","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.005_bib72","doi-asserted-by":"crossref","first-page":"afac073","DOI":"10.1093\/ageing\/afac073","article-title":"Non-inferiority of intranasal ketamine compared to intravenous morphine for musculoskeletal pain relief among older adults in an emergency department: a randomised controlled trial","volume":"51","author":"Tongbua","year":"2022","journal-title":"Age Ageing"},{"issue":"1\u20132","key":"10.1016\/j.anclin.2023.03.005_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pain.2003.07.001","article-title":"Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study","volume":"108","author":"Carr","year":"2004","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib74","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/phar.2669","article-title":"A dose-escalation clinical trial of intranasal ketamine for uncontrolled cancer-related pain","volume":"42","author":"Singh","year":"2022","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.anclin.2023.03.005_bib75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1526-4637.2004.04043.x","article-title":"Subanesthetic Ketamine Infusion Therapy: A Retrospective Analysis of a Novel Therapeutic Approach to Complex Regional Pain Syndrome","volume":"5","author":"Correll","year":"2004","journal-title":"Pain Medicine"},{"issue":"1","key":"10.1016\/j.anclin.2023.03.005_bib76","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/bja\/aev183","article-title":"Racemic ketamine 4.5-day infusion treatment of long-standing complex regional pain syndrome\u2014a prospective service evaluation in five patients","volume":"115","author":"Goebel","year":"2015","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.anclin.2023.03.005_bib77","doi-asserted-by":"crossref","first-page":"379","DOI":"10.36076\/ppj.2010\/13\/379","article-title":"Pharmacodynamic Profiles of Ketamine (R)- and (S)- with 5-Day Inpatient Infusion for the Treatment of Complex Regional Pain Syndrome","volume":"13","author":"Goldberg","year":"2010","journal-title":"Pain Physician"}],"container-title":["Anesthesiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227523000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1932227523000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:04:21Z","timestamp":1761829461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1932227523000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1932227523000186"],"URL":"https:\/\/doi.org\/10.1016\/j.anclin.2023.03.005","relation":{},"ISSN":["1932-2275"],"issn-type":[{"value":"1932-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine for Complex Regional Pain Syndrome","name":"articletitle","label":"Article Title"},{"value":"Anesthesiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anclin.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}